These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12942994)
1. From pharmacotherapy to pathophysiology: emerging mechanisms of apolipoprotein D in psychiatric disorders. Thomas EA; Copolov DL; Sutcliffe JG Curr Mol Med; 2003 Aug; 3(5):408-18. PubMed ID: 12942994 [TBL] [Abstract][Full Text] [Related]
2. Antipsychotic drugs differentially modulate apolipoprotein D in rat brain. Khan MM; Parikh VV; Mahadik SP J Neurochem; 2003 Sep; 86(5):1089-100. PubMed ID: 12911617 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders. Thomas EA; George RC; Sutcliffe JG Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):421-7. PubMed ID: 14623496 [TBL] [Abstract][Full Text] [Related]
4. Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Thomas EA; Dean B; Pavey G; Sutcliffe JG Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4066-71. PubMed ID: 11274430 [TBL] [Abstract][Full Text] [Related]
5. Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia. Yao JK; Thomas EA; Reddy RD; Keshavan MS Schizophr Res; 2005 Jan; 72(2-3):259-66. PubMed ID: 15560970 [TBL] [Abstract][Full Text] [Related]
7. Clozapine specifically alters the arachidonic acid pathway in mice lacking apolipoprotein D. Thomas EA; Yao JK Schizophr Res; 2007 Jan; 89(1-3):147-53. PubMed ID: 17011169 [TBL] [Abstract][Full Text] [Related]
8. The neurobiology of apolipoproteins in psychiatric disorders. Sutcliffe JG; Thomas EA Mol Neurobiol; 2002; 26(2-3):369-88. PubMed ID: 12428765 [TBL] [Abstract][Full Text] [Related]
9. Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy. Thomas EA; Danielson PE; Nelson PA; Pribyl TM; Hilbush BS; Hasel KW; Sutcliffe JG J Neurochem; 2001 Feb; 76(3):789-96. PubMed ID: 11158250 [TBL] [Abstract][Full Text] [Related]
10. Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion. Terrisse L; Séguin D; Bertrand P; Poirier J; Milne R; Rassart E Brain Res Mol Brain Res; 1999 Jun; 70(1):26-35. PubMed ID: 10381540 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein D is associated with long-term outcome in patients with schizophrenia. Hansen T; Hemmingsen RP; Wang AG; Olsen L; Timm S; Søeby K; Jakobsen KD; Fenger M; Parnas J; Rasmussen HB; Werge T Pharmacogenomics J; 2006; 6(2):120-5. PubMed ID: 16402085 [TBL] [Abstract][Full Text] [Related]
12. Cellular cholesterol storage in the Niemann-Pick disease type C mouse is associated with increased expression and defective processing of apolipoprotein D. Suresh S; Yan Z; Patel RC; Patel YC; Patel SC J Neurochem; 1998 Jan; 70(1):242-51. PubMed ID: 9422368 [TBL] [Abstract][Full Text] [Related]
13. Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins. Thomas EA; George RC; Danielson PE; Nelson PA; Warren AJ; Lo D; Sutcliffe JG Mol Psychiatry; 2003 Nov; 8(12):983-93, 950. PubMed ID: 14647396 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization and developmental expression pattern of the chicken apolipoprotein D gene: implications for the evolution of vertebrate lipocalins. Ganfornina MD; Sánchez D; Pagano A; Tonachini L; Descalzi-Cancedda F; Martínez S Dev Dyn; 2005 Jan; 232(1):191-9. PubMed ID: 15580625 [TBL] [Abstract][Full Text] [Related]